Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug costs
Pharma
GLP-1s still unavailable in lower-income countries: MSF
Médecins Sans Frontières urged GLP-1 drug makers to "relinquish their stranglehold" on the meds and license them to generics makers to boost access.
Zoey Becker
Mar 28, 2024 8:00am
Kyowa's Orchard hopes $4.25M gene therapy price tag bears fruit
Mar 20, 2024 10:40am
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
Mar 18, 2024 11:02am
GSK's asthma inhaler market pull draws Warren's ire
Mar 5, 2024 10:57am
Lawmakers blast Biden administration's 'march-in' proposal
Feb 23, 2024 9:53am
PhRMA taps Gilead CEO Dan O'Day as its new board chair
Feb 21, 2024 2:51pm